Does Dr. JEFFREY BENNION have financial conflicts of interest?

Dr. JEFFREY BENNION (M.D.) has received a total of $716 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $716 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. JEFFREY BENNION?

According to CMS Open Payments data, Dr. JEFFREY BENNION received funding from GENZYME CORPORATION ($172), REGENERON HEALTHCARE SOLUTIONS ($165), and ASTRAZENECA PHARMACEUTICALS ($103).

Does Dr. JEFFREY BENNION receive research grants or speaking fees?

Dr. JEFFREY BENNION has received $716 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. JEFFREY BENNION

M.D.Real-Time Hydrated

Specialty: Otolaryngology, Plastic Surgery within the Head & Neck

Practice Location: NORTH LOGAN, UT 84341

NPI Number: 1396731469

LIFETIME INDUSTRY VALUE

$716

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. BENNION is a verified Otolaryngology, Plastic Surgery within the Head & Neck practitioner based in NORTH LOGAN, UT.

Between 2021 and 2025, Dr. BENNION had an overall industry promotional and research financial footprint of $716 as recorded in the federal CMS Open Payments database.

$716 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. BENNION's primary funding source is GENZYME CORPORATION, which accounts for $172 (representing 24.1% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

GENZYME CORPORATION

Rank 1

$172

24.1%

REGENERON HEALTHCARE SOLUTIONS

Rank 2

$165

23.1%

ASTRAZENECA PHARMACEUTICALS

Rank 3

$103

14.4%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.